{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:54:29Z","timestamp":1788051269437,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sanming Project of Shenzhen Health and Family Planning Commission","award":["SZSM201512016"],"award-info":[{"award-number":["SZSM201512016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13577-019-00258-0","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T12:02:48Z","timestamp":1559736168000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma"],"prefix":"10.1007","volume":"32","author":[{"given":"Chang\u2019e","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"258_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccm.2011.09.001","volume":"32","author":"CS Dela Cruz","year":"2011","unstructured":"Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32:605\u201344.","journal-title":"Clin Chest Med"},{"key":"258_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5507\/bp.2013.034","volume":"157","author":"V Koudelakova","year":"2013","unstructured":"Koudelakova V, Kneblova M, Trojanec R, Drabek J, Hajduch M. Non-small cell lung cancer\u2014genetic predictors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:125\u201336.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"258_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"258_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271\u201389.","journal-title":"CA Cancer J Clin"},{"key":"258_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/jcm7080192","volume":"7","author":"KT Bui","year":"2018","unstructured":"Bui KT, Cooper WA, Kao S, Boyer M. Targeted molecular treatments in non-small cell lung cancer: a clinical guide for oncologists. J Clin med. 2018;7:192.","journal-title":"J Clin med."},{"key":"258_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"258_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-5590-1_1","volume":"774","author":"TA Farazi","year":"2013","unstructured":"Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. Adv Exp Med Biol. 2013;774:1\u201320.","journal-title":"Adv Exp Med Biol"},{"key":"258_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4161\/cam.3.4.9913","volume":"3","author":"GR Hime","year":"2009","unstructured":"Hime GR, Somers WG. Micro-RNA mediated regulation of proliferation, self-renewal and differentiation of mammalian stem cells. Cell Adh Migr. 2009;3:425\u201332.","journal-title":"Cell Adh Migr"},{"key":"258_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5306\/wjco.v5.i4.604","volume":"5","author":"VD Vescovo","year":"2014","unstructured":"Vescovo VD, Grasso M, Barbareschi M, Denti MA. MicroRNAs as lung cancer biomarkers. World J Clin Oncol. 2014;5:604\u201320.","journal-title":"World J Clin Oncol"},{"key":"258_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/dvdy.24477","volume":"246","author":"A Shrestha","year":"2017","unstructured":"Shrestha A, Mukhametshina RT, Taghizadeh S, et al. MicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and disease. Dev Dyn. 2017;246:285\u201390.","journal-title":"Dev Dyn"},{"key":"258_CR11","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1158\/1078-0432.CCR-08-1355","volume":"15","author":"X Liu","year":"2009","unstructured":"Liu X, Sempere LF, Galimberti F, et al. Uncovering growth-suppressive microRNAs in lung cancer. Clin Cancer Res. 2009;15:1177\u201383.","journal-title":"Clin Cancer Res"},{"key":"258_CR12","first-page":"10800","volume":"8","author":"P Xiao","year":"2015","unstructured":"Xiao P, Liu WL. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Int J Clin Exp Pathol. 2015;8:10800\u20137.","journal-title":"Int J Clin Exp Pathol"},{"key":"258_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/cpr.12235","volume":"49","author":"XC Cao","year":"2016","unstructured":"Cao XC, Yu Y, Hou LK, et al. MiR-142-3p inhibits cancer cell proliferation by targeting CDC25C. Cell Prolif. 2016;49:58\u201368.","journal-title":"Cell Prolif"},{"key":"258_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.devcel.2013.06.023","volume":"26","author":"R Nimmo","year":"2013","unstructured":"Nimmo R, Ciau-Uitz A, Ruiz-Herguido C, et al. MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny. Dev Cell. 2013;26:237\u201349.","journal-title":"Dev Cell"},{"issue":"4","key":"258_CR15","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.4049\/jimmunol.1401893","volume":"194","author":"AR Naqvi","year":"2015","unstructured":"Naqvi AR, Fordham JB, Nares S. MiR-24, miR-30b, and miR-142-3p regulate phagocytosis in myeloid inflammatory cells. J Immunol. 2015;194(4):1916\u201327.","journal-title":"J Immunol"},{"key":"258_CR16","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1242\/dev.105908","volume":"141","author":"G Carraro","year":"2014","unstructured":"Carraro G, Shrestha A, Rostkovius J, et al. MiR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development. Development. 2014;141:1272\u201381.","journal-title":"Development"},{"key":"258_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.febslet.2011.03.067","volume":"585","author":"L Wu","year":"2011","unstructured":"Wu L, Cai C, Wang X, Liu M, Li X, Tang H. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 2011;585:1322\u201330.","journal-title":"FEBS Lett"},{"key":"258_CR18","doi-asserted-by":"publisher","first-page":"e0143993","DOI":"10.1371\/journal.pone.0143993","volume":"10","author":"A Schwickert","year":"2015","unstructured":"Schwickert A, Weghake E, Br\u00fcggemann K, et al. MicroRNA miR-142-3p inhibits breast cancer cell invasiveness by synchronous targeting of WASL, integrin alpha V, and additional cytoskeletal elements. PLoS One. 2015;10:e0143993.","journal-title":"PLoS One"},{"key":"258_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00109-013-1037-x","volume":"91","author":"WW Shen","year":"2013","unstructured":"Shen WW, Zeng Z, Zhu WX, Fu GH. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. J Mol Med (Berl). 2013;91:989\u20131000.","journal-title":"J Mol Med (Berl)"},{"key":"258_CR20","first-page":"12079","volume":"9","author":"J Zhu","year":"2016","unstructured":"Zhu J, Tian X, Zhang Y, Bai Y, Pei K. MiR-142-3p is a tumor promoter by directly targeting FOXO4 to promote gastric cancer cell growth and suppress cell apoptosis in gastric cancer. Int J Clin Exp Pathol. 2016;9:12079\u201387.","journal-title":"Int J Clin Exp Pathol"},{"key":"258_CR21","doi-asserted-by":"publisher","first-page":"153303381879050","DOI":"10.1177\/1533033818790508","volume":"17","author":"X Gao","year":"2018","unstructured":"Gao X, Xu W, Lu T, Zhou J, Ge X, Hua D. MicroRNA-142-3p promotes cellular invasion of colorectal cancer cells by activation of RAC1. Technol Cancer Res Treat. 2018;17:1533033818790508.","journal-title":"Technol Cancer Res Treat"},{"key":"258_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3892\/ol.2015.4021","volume":"11","author":"Y Li","year":"2016","unstructured":"Li Y, Chen D, Jin L, et al. Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Oncol Lett. 2016;11:1235\u201341.","journal-title":"Oncol Lett"},{"key":"258_CR23","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1096\/fj.13-247288","volume":"28","author":"Z Lei","year":"2014","unstructured":"Lei Z, Xu G, Wang L, et al. MiR-142-3p represses TGF-\u03b2-induced growth inhibition through repression of TGF\u03b2R1 in non-small cell lung cancer. FASEB J. 2014;28:2696\u2013704.","journal-title":"FASEB J"},{"key":"258_CR24","first-page":"689","volume":"20","author":"V Gigu\u00e8re","year":"1999","unstructured":"Gigu\u00e8re V. Orphan nuclear receptors: from gene to function. Endocr Rev. 1999;20:689\u2013725.","journal-title":"Endocr Rev"},{"key":"258_CR25","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.celrep.2015.08.035","volume":"12","author":"N Hermann-Kleiter","year":"2015","unstructured":"Hermann-Kleiter N, Klepsch V, Wallner S, et al. The nuclear orphan receptor NR2F6 is a central checkpoint for cancer immune surveillance. Cell Rep. 2015;12:2072\u201385.","journal-title":"Cell Rep"},{"key":"258_CR26","doi-asserted-by":"publisher","first-page":"E1694","DOI":"10.3390\/ijms17101694","volume":"17","author":"C Niu","year":"2016","unstructured":"Niu C, Sun X, Zhang W, et al. NR2F6 expression correlates with pelvic lymph node metastasis and poor prognosis in early-stage cervical cancer. Int J Mol Sci. 2016;17:E1694.","journal-title":"Int J Mol Sci"},{"key":"258_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2011.05.025","volume":"309","author":"XB Li","year":"2011","unstructured":"Li XB, Jiao S, Sun H, et al. The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells. Cancer Lett. 2011;309:137\u201344.","journal-title":"Cancer Lett"},{"key":"258_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1210\/me.2012-1265","volume":"27","author":"GE Muscat","year":"2013","unstructured":"Muscat GE, Eriksson NA, Byth K, et al. Research resource: nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer. Mol Endocrinol. 2013;27:350\u201365.","journal-title":"Mol Endocrinol"},{"key":"258_CR29","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/leu.2011.137","volume":"25","author":"CV Ichim","year":"2011","unstructured":"Ichim CV, Atkins HL, Iscove NN, Wells RA. Identification of a role for the nuclear receptor EAR-2 in the maintenance of clonogenic status within the leukemia cell hierarchy. Leukemia. 2011;25:1687\u201396.","journal-title":"Leukemia"},{"key":"258_CR30","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/s41467-018-04004-2","volume":"9","author":"V Klepsch","year":"2018","unstructured":"Klepsch V, Hermann-Kleiter N, Do-Dinh P, et al. Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1\/PD-1 cancer immune checkpoint blockade. Nat Commun. 2018;9:1538.","journal-title":"Nat Commun"},{"key":"258_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52\u201367.","journal-title":"Cell"},{"key":"258_CR32","doi-asserted-by":"publisher","first-page":"11051","DOI":"10.1007\/s13277-014-2409-8","volume":"35","author":"H Jian","year":"2014","unstructured":"Jian H, Zhao Y, Liu B, Lu S. SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer. Tumour Biol. 2014;35:11051\u20136.","journal-title":"Tumour Biol"},{"key":"258_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-015-0169-y","volume":"34","author":"H Wang","year":"2015","unstructured":"Wang H, Guan X, Tu Y, et al. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. J Exp Clin Cancer Res. 2015;34:59.","journal-title":"J Exp Clin Cancer Res"},{"key":"258_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter AG, J\u00e4nicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99\u2013104.","journal-title":"Cell Death Differ"},{"key":"258_CR35","doi-asserted-by":"crossref","first-page":"21802","DOI":"10.18632\/oncotarget.5224","volume":"6","author":"R Cui","year":"2015","unstructured":"Cui R, Kim T, Fassan M, et al. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. 2015;6:21802\u201315.","journal-title":"Oncotarget"},{"key":"258_CR36","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/jnci\/87.20.1546","volume":"87","author":"GW Sledge Jr","year":"1995","unstructured":"Sledge GW Jr, Qulali M, Goulet R, et al. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst. 1995;87:1546\u201350.","journal-title":"J Natl Cancer Inst"},{"key":"258_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1006\/scbi.2000.0379","volume":"10","author":"I Stamenkovic","year":"2000","unstructured":"Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000;10:415\u201333.","journal-title":"Semin Cancer Biol"},{"key":"258_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/labinvest.2010.201","volume":"91","author":"K Zhang","year":"2011","unstructured":"Zhang K, Chen D, Jiao X, et al. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrixmetalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest. 2011;91:426\u201338.","journal-title":"Lab Invest"},{"key":"258_CR39","first-page":"1669","volume":"17","author":"XC Yang","year":"2013","unstructured":"Yang XC, Wang X, Luo L, et al. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. Eur Rev Med Pharmacol Sci. 2013;17:1669\u201380.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-019-00258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-019-00258-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-019-00258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:25:56Z","timestamp":1591226756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-019-00258-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1007\/s13577-019-00258-0","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"20 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}